51662-1418 : Nalbuphine Hci 20 mg/ml Intramuscular; Intravenous; Subcutaneous Injection, Solution

Labeler: Hf Acquisition Co LLC, Dba Healthfirst
Product Type: Human Prescription Drug
Drug Name:  Nalbuphine Hci
Dosage Form: Intramuscular; Intravenous; Subcutaneous Injection, Solution
Application #: ANDA070918
Rev. Date: 

NDC Package Codes:

  • 51662-1418-1: 1 VIAL, MULTI‑DOSE IN 1 CARTON (51662‑1418‑1) > 10 ML IN 1 VIAL, MULTI‑DOSE

Active Ingredients:

  • Nalbuphine Hydrochloride

Dosage Strength:

  • 20 mg/mL

Pharmaceutical Classes:

  • Competitive Opioid Antagonists [MoA]
  • Opioid Agonist/Antagonist [EPC]
  • Partial Opioid Agonists [MoA]

Related Products:

Based on records with the same trade name.
  • 51662-1420 Nalbuphine Hci 10 mg/ml Intramuscular; Intravenous; Subcutaneous Injection, Solution by Hf Acquisition Co LLC, Dba Healthfirst


Scan the QR code below to easily reference this data in the future:

NDC 51662-1418 QR Code

< Prev: 51662-1416Next: 51662-1419 >

Related Discussions:

Nalbuphine Availability
I have an active prescription for Nalbuphine but can't seem to get it filled anywhere. The FDA website has been upda... 7 replies
Nalbuphine inj.
I live in Los Angeles, Ca. Im trying to get Nalbuphine inj, The pharmacys dont have it.. Do someone know where to get it... 3 replies
expired nalbuphine s affects if accidently taken
Affects of expired nalbuphine , if taken Accidently, ## Hi, Nalbuphine inj expired from 4years ago and taken by i.v acci... 1 reply
Coming off of Kinz (Nalbuphine) 20mg inj.
I have been taking Kinz for the past three years, but when I stop the craving is unbearable. Is there a safe and effecti...

Note: The MedsChat® NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.